.jpg?cb=5814680665433cc71e4f5bd2d8112904)
Novo Holdings will acquire an approximately 60% controlling stake in Singe Use Support, alongside the two company founders who will each retain 10% and Danaher which will retain 20% of the share capital.
Related Posts
Merck Acquire Mirus Bio for $600 Million
Merck has signed a definitive agreement to acquire life science company Mirus Bio for $600 million. Mirus Bio is a specialist in the development…
Telix Pharma to Acquire QSAM Biosciences
Telix has announced it has entered into an agreement to acquire QSAM Biosciences, Inc. and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM…
.jpg?cb=3956bc47ff8120264eabc4e54f200e5c&w=1200)
AstraZeneca Complete Fusion Acquisition – European Pharmaceutical Manufacturer
Last week, AstraZeneca announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates…